N/A
N=60
Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke
Stroke, Acute · Cerebral Infarction
Bottom Line
View on ClinicalTrials.gov: NCT03741400 ↗Enrolled (actual)
60
Serious AEs
1.7%
Results posted
Oct 2024
Primary outcome: Primary: Change in Functional Impairment, Jebsen Taylor Hand Function Test — 119; 181; -69; -64 seconds — p=0.88
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Neofect RAPAEL Smart Glove (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Sep 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Functional Impairment, Jebsen Taylor Hand Function Test |
119; 181; -69; -64; 87; 131 | 0.88 |
| SECONDARY Change in Functional Impairment, Upper Extremity Fugl-Meyer Assessment |
55; 46; 8; 8 | 0.61 |
| SECONDARY Persistence of Treatment Effects at 24 Weeks in Jebsen Taylor Hand Function Test |
119; 181; -47; -82; 87; 131 | 0.47 |
| SECONDARY Persistence of Treatment Effects at 24 Weeks in Upper Extremity Fugl-Meyer Test |
55; 46; 7; 11 | 0.24 |
| SECONDARY Total Dose of Upper Extremity Rehabilitation |
584; 1434 | 0.18 |
| SECONDARY Self-rated Stroke-related Disability Between Each Treatment Group |
63; 65; 75; 82.5 | 0.926 |
Summary
The Virtual Reality Glove for Hand and Arm Rehabilitation (vREHAB) trial is a randomized, controlled, phase 3 trial aiming to evaluate the safety, usability, and efficacy of a virtual reality biofeedback system (Neofect RAPAEL Smart Glove) to promote recovery of distal arm and hand function in the acute and subacute period after stroke, as compared to standard of care therapy. The aims of the study is to demonstrate:
1. the effect of Smart Glove use on functional recovery, in addition to standard of care rehabilitation therapy.
2. the feasibility of increasing the dose of rehabilitation in acute stroke patients with the Smart Glove.
3. the effect of Smart Glove use on quality of life.
Eligibility Criteria
Inclusion Criteria
- a diagnosis of ischemic or hemorrhagic stroke prior to enrollment.
- unilateral hand/arm weakness from stroke with indication for upper limb rehabilitation therapy.
- ability to successfully play 2 out 4 pre-selected test games with the Smart Glove. The test specific games and criteria for passing are as follows:
- Pour the wine (Pronation/Supination): make 5 pours in first 1 minute
- Snow Ball Fight (Wrist Flexion/Extension w/ gravity eliminated): take down 3 objects in first 1 minute
- Scrub the Floor (Wrist Radial/Ulnar deviation w/ gravity eliminated): scrub the floor 5 times in first 1 minute
- Float the Fish (Finger Flexion/Extension): make 50 meters with 3 or less bumps in first 3 minutes
Exclusion Criteria
- Age <18 years
- history of visually provoked seizures
- psychological disorder that could impede participation
- pre-existing neurologic disorder which causes significant deficits in arm/hand function (e.g. Parkinson's disease, peripheral neuropathy, etc.)
- severe receptive aphasia which results in inability to participate with the Smart Glove.
- cognitive impairment which results in inability to participate with the Smart Glove.
- severe pain impeding upper extremity rehabilitation and use of the Smart Glove
- limited life-expectancy which makes it unlikely that patient will be able to complete the 24-week follow-up visit
- any medical or other condition that, in the opinion of the investigator, makes the patient unsuitable for participation in this study.
Data sourced from ClinicalTrials.gov (NCT03741400). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.